期刊文献+

法舒地尔联合左卡尼汀治疗缺血性心肌病39例临床观察 被引量:2

Clinical observation on treating ischemic cardiomyopathy using Fasudil and L-carnitine
原文传递
导出
摘要 缺血性心肌病是心内科的常见疾病。尤其是冠心病(CHD)晚期导致慢性心力衰竭(CHF),病死率居高不下。本研究采用Rho激酶抑制剂法舒地尔联合左卡尼汀治疗CHD慢性心力衰竭,旨在探讨法舒地尔联合左卡尼汀治疗冠心病心衰的临床效果,并为其应用提供更多的临床资料。
作者 张晓璐 葛华
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第5期376-377,共2页 Chinese Journal of Practical Internal Medicine
关键词 法舒地尔 左卡尼汀 缺血性心肌病 fasudil Levocarnifine ischemic cardiomyopathy
  • 相关文献

参考文献4

二级参考文献15

  • 1黄伟青,梁子敬.老年心肺联合疾病院前急症发生特点分析[J].实用老年医学,2005,19(4):196-197. 被引量:4
  • 2童朝阳,顾国嵘,顾俭勇,姜燕飞,黄培志.无创血流动力学监测在急性呼吸困难鉴别诊断中的意义[J].中国临床医学,2005,12(6):1128-1129. 被引量:5
  • 3Hisaoka T, Yano M, Ohkusa T, et al. Enhancement of Rho/Rho kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure. Cardiovasc Res, 2001,49: 319-329. 被引量:1
  • 4Suematsu N, Satoh S, Kinugawa S, et al. Alpha1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol, 2001, 281: H637- H646. 被引量:1
  • 5Touyz RM, Fareh J, Thibault G, et al. Intracellular Ca^2+ modulation by angiotensin Ⅱ and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension, 1996, 28: 797-805. 被引量:1
  • 6Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase(Rho-kinase). J Biol Chem, 1996, 271: 20246-20249. 被引量:1
  • 7Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. J Circ Res, 2000, 87:173-175. 被引量:1
  • 8Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. Cardiovasc Pharma,2002,39: 319-327. 被引量:1
  • 9Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. J Circ Res, 1994, 74: 555-564. 被引量:1
  • 10Shoemaker WC,Wo CC,Chan L,et al.Outcome prediction of emergency patients by noninvasive hemodynamic monitoring[J].Chest,2001,120(2):528-537. 被引量:1

共引文献66

同被引文献18

  • 1韩雅玲,于海波,闫承慧,孟子敏,张效林,康建,李少华,王士雯.血清反应因子参与RhoA诱导的人血管内皮细胞肌动蛋白骨架重构[J].生理学报,2005,57(3):295-302. 被引量:8
  • 2Zalcman G, Closson V, Linarbs-Cruz G, et al. Regulation of Ras- related RhoB protein expression during the cell cycle [ J ]. Onco- gene, 1995,10(10) :1935-1945. 被引量:1
  • 3Zhou Q, Gensch C, Liao JK. Rho-associated coiled-coil-forming kinases (ROCKs) : potential targets for the treatment of atheroscle- rosis and vascular disease [ J ]. Trends Pharmacol Sci, 2011,32 (3) :167-173. 被引量:1
  • 4Dong M, Yan BP, Yu CM. Current status of rho-associated kinase (ROCKs) in coronary atherosclerosis and vasospasm [ J ]. Cardio- vasc Hematol Agents Med Chem, 2009,7(4) :322-330. 被引量:1
  • 5Shimokawa H. Rho-kinase as a novel therapeutic targetin in treat- ment of cardiovascular diseases[J]. Cardiovasc Pharrnacol, 2002, 39(3) :319-327. 被引量:1
  • 6Knock GA, Snetkov VA, Shaifta Y, et al. Superoxide cunstr/ets rat pulmonary arteries via Rho-kinase-mediated Ca(2 + ) sensitiza- tion[ J]. Free Radic Biol Med, 2009,46(5) :633-642. 被引量:1
  • 7Shinokawa, Takeshita A. Rho-Kinase is an important therapeutic target in cardiovascularmedicine[ J]. Arterioscler Thromb Vasc Bi- ol, 2005,25 (9) : 1757-1775. 被引量:1
  • 8Vaughand E. PAI-1 and atherothrombosis[ J]. J Thromb Haemost, 2005,3(8) :1879-1883. 被引量:1
  • 9Kobayashi N, Nakano S, Mita S, et al. Involvement of Rhokinase pathway for angiotensin Ⅱ -induced plasminogen active-tot inhibitor- 1 gene expression and cardiovascular remodeling in hypertensive rats [ J ]. Pharmaeol Exp Ther, 2002,301 (2) :459-466. 被引量:1
  • 10Bicakcigil M, Tasan D, Tasdelen N, et al. Role of fibrinolytic pa- rameters and plasminogen activator inhibitor 1 ( PAI-1 ) promoter polymorphism on premature athemsclerosis in sle patients [ J ]. Lu- pus, 2011,20(10) :1063-1071. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部